'Outstanding Data': Mosunetuzumab in R/R Follicular Lymphoma
The investigational monoclonal antibody showed impressive activity in patients with follicular lymphoma that had relapsed or was refractory to a median of 3 prior lines of therapy.
Medscape Medical News
source https://www.medscape.com/viewarticle/964647?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/964647?src=rss
Comments
Post a Comment